← back to database
Acorn Bioventures provides capital and strategic partnerships to biotech, specialty pharma, and medical device companies. It focuses on private, small-cap firms and collaborates with portfolio companies to accelerate growth. The firm operates as a venture capital investor based in New York, founded in 2017. This B2B-focused model supports companies in biotechnology, pharmaceutical, medical technology, and medicine sectors. The approach aims to build a diversified portfolio across life sciences.
Investment focus
Investment style
Specialist
Investing team
- Anders HoveFounder & Partner
- Isaac MankePartner
- Max LewinVice President
- Gabriel SchneiderVice President
- Rakesh AhujaAnalyst